The study of gene expression is opening new doors for drug discovery. Our epigenetics solutions include cellular detection kits and epigenetic assays for readers, writers, and erasers – allowing you to characterize multiple targets, shorten assay development time, and accelerate drug discovery.
Drugs that can alter cellular traits gave particular importance for conditions related to epigenetic modification, including cancer, mental illness, and heart disease. As knowledge of gene expression in disease states advances, so too does the possibility for epigenetic drugs.
Our epigenetic portfolio includes high quality reagents, readers and automation.